FBLG ▲ +2.1% - FibroBiologics, Inc. $FBLG - FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing FibroBiologics rose 2.1% following its announcement of a newly issued U.S. patent covering the therapeutic use of fibroblasts in wound healing. The patent grant strengthens the company's intellectual property position in its core regenerative medicine field and provides expanded protection for its fibroblast-based treatment approach. 03-SEP-2026 08:31 AM ET